Neuropeptides, trophic factors, and other substances providing morphofunctional and metabolic protection in experimental models of diabetic retinopathy.

作者: Krisztina Szabadfi , Erika Pinter , Dora Reglodi , Robert Gabriel , None

DOI: 10.1016/B978-0-12-800179-0.00001-5

关键词: Drug developmentDiabetes mellitusType 2 diabetesBiologyEndocrinologyInternal medicinePathologicalRetinopathyType 1 diabetesDiseaseDiabetic retinopathyBioinformatics

摘要: Vision is the most important sensory modality for many species, including humans. Damage to retina results in vision loss or even blindness. One of serious complications diabetes, a disease that has seen worldwide increase prevalence, diabetic retinopathy. This condition stems from consequences pathological metabolism and develops 75% patients with type 1 50% 2 diabetes. The development novel protective drugs essential. In this review we provide description conclude diabetes lead same We evaluate existing experimental models recent developments finding effective compounds against disorder. our opinion, best are long-term streptozotocin-induced Otsuka Long-Evans Tokushima Fatty spontaneously Torii rats, while promising substances topically administered somatostatin pigment epithelium-derived factor analogs, antivasculogenic substances, systemic antioxidants. Future drug should focus on these.

参考文章(422)
M Mizutani, T S Kern, M Lorenzi, Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy. Journal of Clinical Investigation. ,vol. 97, pp. 2883- 2890 ,(1996) , 10.1172/JCI118746
Hideaki Miyajima, Makoto Osanai, Hideki Chiba, Nami Nishikiori, Takashi Kojima, Kenji Ohtsuka, Norimasa Sawada, Glyceraldehyde-derived advanced glycation end-products preferentially induce VEGF expression and reduce GDNF expression in human astrocytes. Biochemical and Biophysical Research Communications. ,vol. 330, pp. 361- 366 ,(2005) , 10.1016/J.BBRC.2005.03.001
Ignasi Barba, Marta Garcia-Ramírez, Cristina Hernández, María Angeles Alonso, Lluis Masmiquel, David García-Dorado, Rafael Simó, Metabolic fingerprints of proliferative diabetic retinopathy: an 1H-NMR-based metabonomic approach using vitreous humor. Investigative Ophthalmology & Visual Science. ,vol. 51, pp. 4416- 4421 ,(2010) , 10.1167/IOVS.10-5348
Li-ping Yang, Hui-li Sun, Le-meng Wu, Xiu-juan Guo, Hong-liang Dou, Mark O. M. Tso, Lin Zhao, Shun-min Li, Baicalein reduces inflammatory process in a rodent model of diabetic retinopathy. Investigative Ophthalmology & Visual Science. ,vol. 50, pp. 2319- 2327 ,(2009) , 10.1167/IOVS.08-2642
Timothy S. Kern, Contributions of Inflammatory Processes to the Development of the Early Stages of Diabetic Retinopathy Experimental Diabetes Research. ,vol. 2007, pp. 95103- 95103 ,(2007) , 10.1155/2007/95103
S.B. Smith, Diabetic Retinopathy and the NMDA receptor Drug News & Perspectives. ,vol. 15, pp. 226- 232 ,(2002) , 10.1358/DNP.2002.15.4.840055
Timothy S. Kern, Ronald L. Engerman, Comparison of retinal lesions in alloxan-diabetic rats and galactose-fed rats. Current Eye Research. ,vol. 13, pp. 863- 867 ,(1994) , 10.3109/02713689409015087
Ryotaro Goto, Motoaki Doi, Ning Ma, Reiji Semba, Yukitaka Uji, Contribution of nitric oxide-producing cells in normal and diabetic rat retina. Japanese Journal of Ophthalmology. ,vol. 49, pp. 363- 370 ,(2005) , 10.1007/S10384-004-0213-5
Yumiko Yoshida, Sho-Ichi Yamagishi, Takanori Matsui, Yuko Jinnouchi, Kei Fukami, Tsutomu Imaizumi, Ryoji Yamakawa, Protective role of pigment epithelium-derived factor (PEDF) in early phase of experimental diabetic retinopathy Diabetes/Metabolism Research and Reviews. ,vol. 25, pp. 678- 686 ,(2009) , 10.1002/DMRR.1007
A. Gonçalves, E. Leal, A. Paiva, E. Teixeira Lemos, F. Teixeira, C. F. Ribeiro, F. Reis, A. F. Ambrósio, R. Fernandes, Protective effects of the dipeptidyl peptidase IV inhibitor sitagliptin in the blood–retinal barrier in a type 2 diabetes animal model Diabetes, Obesity and Metabolism. ,vol. 14, pp. 454- 463 ,(2012) , 10.1111/J.1463-1326.2011.01548.X